Home LiteratureArticle Details
PMID: 3135804 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Phosphatidylinositol-specific phospholipase D: a pathway for generation of a second messenger.

Biochemical and biophysical research communications ·Vol. 154 ·No. 2 ·1988-07-29 ·Pages 502-8

Balsinde J, Diez E, Mollinedo F

Abstract

We have found a phospholipase D activity in the postnuclear fraction of human neutrophils which is stimulated by incubation of cells with the calcium ionophore A23187. The phospholipase D activity was assessed by both phosphatidate formation and free inositol release from phosphatidylinositol substrate. The phospholipase D activity shows an optimum pH of 7.5 and hydrolyzes specifically phosphatidylinositol. These results suggest that this phosphatidylinositol-specific phospholipase D can play a role in cell activating process.

MeSH Terms
Calcimycin/pharmacology Humans Hydrogen-Ion Concentration Neutrophils/drug effects,metabolism Phosphatidylcholines/blood Phosphatidylinositols/blood Phospholipase D/blood Phospholipases/blood Type C Phospholipases/blood
Chemicals
Phosphatidylcholines Phosphatidylinositols Calcimycin Phospholipases Type C Phospholipases Phospholipase D
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Balsinde J
Unidad de Biomembranas Centro de Investigaciones Biológicas, C.S.I.C., Madrid, Spain.
Diez E
Mollinedo F
Article Info
Journal
Biochemical and biophysical research communications
Abbr.
Biochem Biophys Res Commun
ISSN
0006-291X
Published
1988-07-29
Pages
502-8
Language
English
Region
United States
NLM ID
0372516
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com